Internal Medicine, Nephrology · Benson, AZ
NPI
1023014586
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
450 S Ocotillo Ave
Benson, AZ, 85602
Phone (520) 623-2642
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
4,662 services
Medicare patients, 2024
616
Average age 77
Drug cost, 2024
$1.6M
2,783 prescriptions
Company payments, 2025
$527
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul E Walshaw was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 768 times for 399 patients. In total Paul E Walshaw billed 4,662 services in 48 codes, and Medicare paid $191K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 768 | 399 | $11.98 | $9,199 |
| 99214 Office E&M - Established | Office | 567 | 349 | $84.12 | $48K |
| 36415 Venipuncture Blood Collection | Office | 408 | 222 | $5.87 | $2,394 |
| 80048 Clinical Chemistry | Office | 295 | 170 | $8.29 | $2,446 |
| 99232 Hospital E&M - Subsequent | Facility | 264 | 119 | $57.79 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 174 | 58 | $48.27 | $8,399 |
| 99233 Hospital E&M - Subsequent | Facility | 173 | 75 | $86.54 | $15K |
| 83970 Clinical Chemistry | Office | 171 | 94 | $40.45 | $6,917 |
| 99215 Office E&M - Established | Office | 159 | 84 | $128.61 | $20K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 128 | 58 | $36.95 | $4,730 |
| 80069 Clinical Chemistry | Office | 106 | 60 | $8.51 | $902 |
| 99223 Hospital E&M - Initial | Facility | 100 | 95 | $126.53 | $13K |
| 85027 Blood Count | Office | 98 | 53 | $6.34 | $621 |
| 99204 Office E&M - New | Office | 85 | 85 | $117.66 | $10K |
| 90960 ESRD Related Services (not dialysis) | Office | 80 | 14 | $264.92 | $21K |
By year: 2022 $174K for 2,868 services; 2023 $161K for 3,331 services; 2024 $191K for 4,662 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 408 | 222 | $5.87 | $2,394 |
| 80048 Clinical Chemistry | 295 | 170 | $8.29 | $2,446 |
| 83970 Clinical Chemistry | 171 | 94 | $40.45 | $6,917 |
| 80069 Clinical Chemistry | 106 | 60 | $8.51 | $902 |
| 85027 Blood Count | 98 | 53 | $6.34 | $621 |
| 81002 Clinical Chemistry | 55 | 53 | $3.41 | $188 |
| 82570 Clinical Chemistry | 38 | 25 | $5.08 | $193 |
| 84156 Clinical Chemistry | 38 | 25 | $3.60 | $137 |
| 80053 Clinical Chemistry | 29 | 19 | $10.35 | $300 |
| 84550 Clinical Chemistry | 27 | 22 | $4.43 | $120 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul E Walshaw prescribed most often to Medicare patients was Amlodipine Besylate, with 341 prescriptions and refills. In total Paul E Walshaw wrote 2,783 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 341 | 942 | 112 | $2,219 |
| Furosemide Generic | 290 | 798 | 99 | $2,493 |
| Lisinopril Generic | 260 | 710 | 86 | $1,441 |
| Losartan Potassium Generic | 198 | 594 | 68 | $2,051 |
| Calcitriol Generic | 195 | 543 | 65 | $5,963 |
| Allopurinol Generic | 122 | 328 | 35 | $1,062 |
| Doxazosin Mesylate Generic | 112 | 305 | 39 | $2,613 |
| Hydralazine Hcl Generic | 101 | 289 | 43 | $1,984 |
| Carvedilol Generic | 98 | 297 | 35 | $1,106 |
| Potassium Chloride Generic | 87 | 254 | 34 | $1,426 |
| Tamsulosin Hcl Generic | 61 | 150 | 22 | $705 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 46 | 137 | 15 | $272 |
| Metoprolol Succinate Generic | 45 | 109 | 15 | $284 |
| Torsemide Generic | 44 | 118 | 20 | $945 |
| Prednisone Generic | 43 | 75 | 11 | $285 |
Brand drugs: - claims; generic drugs: 2,518 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul E Walshaw $527 ($527 in general payments such as food, travel and fees) from 9 companies. The largest payer was Vantive US Healthcare LLC with $149.
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 1 | $149 |
| Fresenius USA Marketing, Inc. | 6 | $139 |
| Amgen Inc. AMGN | 4 | $70 |
| Calliditas Therapeutics US Inc. | 2 | $41.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $30.54 |
| Ardelyx, Inc. ARDX | 1 | $28.26 |
| Novo Nordisk Inc NVO | 1 | $27.83 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $23.68 |
| Mallinckrodt Hospital Products Inc. | 1 | $17.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.